5-((3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(4-methylbenzyl)-2-thioxothiazolidin-4-one

Catalog No. :
ACKOMR683
CAS No. :
623935-61-5
Molecular Formula :
C27H20FN3OS2
Molecular Weight :
485.61

IUPAC Name:(Z)-5-((3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(4-methylbenzyl)-2-thioxothiazolidin-4-one

5-((3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(4-methylbenzyl)-2-thioxothiazolidin-4-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-((3-(4-Fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(4-methylbenzyl)-2-thioxothiazolidin-4-one
IUPAC Name(Z)-5-((3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl)methylene)-3-(4-methylbenzyl)-2-thioxothiazolidin-4-one
Molecular FormulaC27H20FN3OS2
Molecular Weight485.61
SMILESO=C1N(CC2=CC=C(C)C=C2)C(S/C1=C\C3=CN(C4=CC=CC=C4)N=C3C5=CC=C(F)C=C5)=S
InChI KeySZPYKADOLVLTME-IWIPYMOSSA-N
SynonymSALOR-INT L437018-1EA;(5Z)-5-([3-(4-FLUOROPHENYL)-1-PHENYL-1H-PYRAZOL-4-YL]METHYLENE)-3-(4-METHYLBENZYL)-2-THIOXO-1,3-THIAZOLIDIN-4-ONE;4-Thiazolidinone, 5-[[3-(4-fluorophenyl)-1-phenyl-1H-pyrazol-4-yl]methylene]-3-[(4-methylphenyl)methyl]-2-thioxo-
CAS No.623935-61-5

Synthetic Route by SureRoute

1. ACKOMR683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACIWAF034 route compound structure diagram
    ACIWAF03436640-40-1
  4. Then
  5. ACKOMR683 route product structure diagram
    ACKOMR683623935-61-5
Inquiry

2. ACKOMR683 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACKOMR683 route product structure diagram
    ACKOMR683623935-61-5
Inquiry

Comments (0)